Event Details



21 September 2017



Webinar: Dealing with Out of Domain (Q)SAR Predictions for ICH M7: A Regulatory and Industrial Perspective


Lhasa Limited hosts various webinars. Check our events list for further details.

This webinar explored out of domain (Q)SAR predictions for the ICH M7 mutagenic impurity use-case. 

The regulatory and industry speakers were Naomi Kruhlak, U.S. FDA and Michelle Kenyon, Pfizer. 

Naomi described the current thinking on how to deal with out of domain (Q)SAR Predictions for ICH M7 before passing on to Michelle who provided an industry perspective.


A recording and slides from this webinar can be found via the link below.  

  • Headline Event (shown first above featured)

  • Featured Event

Related Publications

Back to events

This is a printable version of https://www.lhasalimited.org/events/webinar-dealing-with-out-of-domain-qsar-predictions-for-ich-m7-a-regulatory-and-industrial-perspective/4418?pr=